Johns Hopkins Oncology Center ORA

Baltimore, Maryland 21231

0 studies enrolling now · 2 studies all time

What they study most

Non-Hodgkin Lymphoma, Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia

Studies at this site

• Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients — Completed
• Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. — Completed